# Study to Investigate if the Uptake of Ticagrelor Into the Body Differs Depending on Method of Administration.

> **NCT01887626** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 36 (actual)

## Conditions studied

- Bioavailability Heathy Volunteers

## Interventions

- **DRUG:** Ticagrelor 90 mg whole tablet
- **DRUG:** Ticagrelor 90 mg tablet crushed
- **DRUG:** Dispersed ticagrelor 90 mg tablet suspended in water - nasogastric tube

## Key facts

- **NCT ID:** NCT01887626
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2013-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01887626

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01887626, "Study to Investigate if the Uptake of Ticagrelor Into the Body Differs Depending on Method of Administration.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01887626. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*